Here’s whether Merck & Co., Inc. (MRK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.12% over 10 days); RSI 42 — healthy momentum range; strong 1-year return of +45.5%; rising volume confirms the move (1.17x 30d avg). Currently 4.9% off its 52-week high. Score: +7/7.
MRK is in a confirmed uptrend, trading above both its 50-day ($116.18) and 200-day ($104.78) moving averages. An RSI of 42.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +45.5% compares to +22.9% for SPY (beat the market by 22.6%).
$10,000 invested 1 year ago→ $14,550 today
vs. S&P 500 (SPY) — same period beat market by 22.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($104.78)
✓Above 50-day MA ($116.18)
✓RSI(14) neutral zone (30–70) — currently 42.0
✓Positive return (+45.5%)
✓Within 10% of period high (−4.9%)
Period Range $119.05
$76.66$125.14
RSI (14) 42.0
0 · OversoldOverbought · 100
Key Metrics
Price$119.05
Period Return+45.5%
Period High$125.14
Period Low$76.66
Drawdown−4.9%
MA-50$116.18
MA-200$104.78
RSI (14)42.0
Avg Volume (30d)9.7M
vs. SPYbeat by 22.6%
Return Rank#362 of 1246
Trend Signals
Price is above the 200-day moving average ($104.78)
Price is above the 50-day moving average ($116.18)